Firebrick Pharma Limited (ASX:FRE)
Australia · Delayed Price · Currency is AUD 0.0300
0.00 (0.00%)
Sep 11, 2026, 9:59 AM AEST
Firebrick Pharma Market Cap
Firebrick Pharma has a market cap or net worth of 8.56 million as of September 11, 2026. Its market cap has decreased by -51.18% in one year.
Market Cap
8.56M
Enterprise Value
7.23M
Revenue
135.62K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
ChartMarket Cap Chart
Since January 28, 2022, Firebrick Pharma's market cap has decreased from 89.49M to 8.56M, a decrease of -90.44%. That is a compound annual growth rate of -39.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 8.56M | -35.52% |
| Dec 30, 2025 | 13.27M | 1.87% |
| Dec 31, 2024 | 13.03M | 46.33% |
| Dec 29, 2023 | 8.90M | -77.12% |
| Dec 29, 2022 | 38.92M | -56.51% |
| Jan 28, 2022 | 89.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 81.99B |
| Sigma Healthcare | 30.71B |
| Pro Medicus | 17.40B |
| Ramsay Health Care | 12.27B |
| AdAlta | 9.64M |
| ECS Botanics Holdings | 9.58M |
| Vectus Biosystems | 9.56M |
| Careteq | 9.53M |